Articles

PP24 Is it possible to create an index that can predict who may never need treatment for B-CLL?

BJH - 2018, issue Abstract Book BHS, february 2018

V. Galle MD, P. Vlummens MD, F. Offner MD, PhD

Read more

P36 Can CLL-IPI at time of diagnosis predict who may never need treatment for B-CLL?

BJH - 2018, issue Abstract Book BHS, february 2018

V. Galle MD, P. Vlummens MD, F. Offner MD, PhD

Read more

P45 Donor cell derived deletion 7q occurring after allogeneic stem cell transplantation: a case report

BJH - 2018, issue Abstract Book BHS, february 2018

dr. A. Delie MD, P. Vlummens MD, N. Van Roy PhD, F. Offner MD, PhD, T. Kerre MD, PhD

Read more

PP21 The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results from a multicenter study

BJH - 2018, issue Abstract Book BHS, february 2018

B. Stamatopoulos , T. Smith , E. Crompot , K. Pieters , R. Clifford , M. Mraz , P. Robbe , A. Burns , A. Timbs , D. Bruce , P. Hillmen , N. Meuleman MD, PhD, P. Mineur MD, R. Firescu , M. Maerevoet MD, V. De Wilde MD, PhD, A. Efira MD, J. Philippé MD, PhD, B. Verhasselt MD, PhD, F. Offner MD, PhD, A. Heger , D. Sims , H. Dreau , A. Schuh

Read more

P14 The impact of the updated IMWG diagnostic criteria in a real-life SMM cohort: a single center experience

BJH - volume 8, issue Abstract Book BHS, february 2017

P. Vlummens MD, F. Offner MD, PhD

Read more

P17 Diagnostic strength of bone marrow aspirate versus biopsy in (smoldering) multiple myeloma patients

BJH - volume 8, issue Abstract Book BHS, february 2017

P. Vlummens MD, F. Offner MD, PhD

Read more

Improving care for critically ill haematological patients in the ICU: a modern perspective

BJH - volume 7, issue 3, june 2016

I. Moors MD, P. Depuydt MD, PhD, F. Offner MD, PhD, D. Benoit MD, PhD

Summary

Outcome of critically ill haematological patients in the intensive care unit has substantially improved during the past decades, with current estimates for intensive care unit survival of 70–75% and one-year survival of 40–45%. Based on new insights, the approach towards critically ill haematological patients is changing, with a focus on early recognition of deteriorating patients in the ward and early referral to the intensive care unit when necessary. Broad admission policies should become the standard, with regular re-assessment of the level of care administered, relative to survival expectations and burden for the patient and family. Close collaboration and communication between attending intensivists and referring haematologists with complementary skills is essential to provide good quality of care, be it either achieving short- and long-term survival and good quality of life, or timely withdrawal of aggressive therapy and institution of appropriate comfort care.

(BELG J HEMATOL 2016; 7(3):112–7)

Read more